WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that 60 Degrees Pharmaceuticals, Inc., (NASDAQ: SXTP; SXTPW) specialists in developing and marketing medicines for infectious diseases, has completed its previously announced Public Offering of 5,260,901 units at a price to the public of $0.385 per Unit and 999,076 pre‑funded units at a price to the public of $0.375 per Pre‑Funded Unit.
The underwriters were granted an option, exercisable within 45 days after the closing of the offering, to purchase shares of 60P’s common stock at a price of $0.385 per share and/or Warrants at a price of $0.01 per Warrant and/or Pre-Funded Warrants at a price of $0.375 per Pre-Funded Warrant, or any combination of additional shares of common stock, Warrants and/or Pre-Funded Warrants, representing, in the aggregate, up to 15% of the number of Units sold in the offering, 15% of the Warrants underlying the Units and Pre-Funded Units sold in the offering and 15% of the Pre-Funded Warrants underlying the Pre-Funded Units sold in the offering, in all cases less the underwriting discount to cover over-allotments, if any. On January 31, 2024, WallachBeth Capital LLC partially exercised its over-allotment option with respect to 818,177 Warrants.
WallachBeth Capital LLC is the Sole Bookrunner for the offering.
About WallachBeth Capital LLC
WallachBeth Capital offers a robust range of capital markets and investment banking services to the healthcare community. The firm’s experience includes initial public offerings, follow-on issues, PIPE offerings, and private transactions. The firm’s website is located at www.wallachbeth.com.
